Just Released - Transplantation Journal - February 2026

Transplantation sciences have uniquely advanced the clinical art over the last 70 years. Federal funding has always been critical. Since November 2024, the NIH has inaugurated a transplant specific study section that will play a critical role in shaping the future of transplantation research. A special feature in this issue of the journal authored by the inaugural chair, presents an in-depth assessment of this committee’s role and perspective.


Continue Reading

Tailoring and optimizing immunosuppression continue to be at the center of any transplant provider. While CNIs represent the mainstay of immunosuppression, side-effects are broadly recognized. Maintenance immunosuppression avoiding CNIs has the advantage of evading some of those side-effects. Belatacept-based regimens, however, have also indicated a higher risk of acute rejections. A review article by key opinion leaders in this issue of the journal, presents data on an optimized conversion to Belatacept.

Novel preservation techniques show great potential with promise to assess, select, preserve and potentially improve organ function. Two experimental studies provide details: Innovative methods are applied to discarded human hearts focusing on incorporating mitochondrial redox state, left ventricular (LV) function, and inflammatory biomarkers into normothermic machine perfusion (NMP) protocols. An additional experimental study in kidneys applied a multi-omics approach to delineate the consequences of preservation and prolonged ischemia.

The diagnosis of Chronic Antibody mediated rejection continues to be a clinical challenge. Peritubular Capillary multilayering is a key diagnostic feature, nevertheless this lesion has not been well defined while variable diagnostic thresholds and criteria have been used. A single center, prospective cohort study provides a detailed analysis and presents peritubular capillary multilayering as a superior histological marker of Chronic Antibody mediated Rejection with high sensitivity.

Enjoy this February issue of the journal with many more highlights.

Stefan G. Tullius, MD, PhD
Editor-in-Chief, Transplantation Journals



TTS 2026 - Plan Ahead & Submit Your Abstract!

Plan ahead for TTS 2026 — review the week-at-a-glance

The TTS2026 Scientific Program Committee invites the global transplantation community to submit original scientific abstracts.

📅 Submission deadline: March 19, 2026 — 23:59 (EST)


Call for Nominations Reminder - DEADLINE: FEBRUARY 18, 2026

In 2026, three Officer positions will be vacated and 5 of the 14 Councilors-at-large representing the Regions will be changing. The elections will take place in early 2026 and those elected will assume their new roles starting at the 2026 TTS Congress in Sydney.



Transplantation Journal Highlights

Transplantation Journal - Social Media Content

Improved DCD Heart Transplant Function Through Ferroptosis Blockade in a Model of Experimental Normothermic Ex Vivo Perfusion
Adopting donation after circulatory death (DCD) hearts can increase the donor pool. However, DCD hearts experience severe ischemia–reperfusion injury (IRI). Ferroptosis is a key contributor to organ IRI. Liproxstatin-1 (Lip-1), a selective ferroptosis inhibitor, markedly suppresses this form of cell death. This study evaluated the cardioprotective effect of Lip-1 on DCD hearts preserved with normothermic ex vivo heart perfusion (EVHP) in a rat heart transplantation model.
Adjuvant IL-15 Blockade Significantly Improves Survival in a CD28-based Immunosuppression Protocol of Pig-to-nonhuman Primate Renal Xenotransplantation
Xenotransplantation has emerged as a promising solution to the critical organ shortage, with encouraging results in preclinical nonhuman primate studies and recent first-in-human transplants. Our group previously performed pig-to-rhesus macaque renal xenotransplants using the clinically available costimulation blockade agent belatacept; however, graft survival was modest (>1 moh). Analysis of rejected xenografts identified natural killer (NK) cells as a predominant infiltrating population.

Transplantation Direct - Social Media Content

MicroRNA Profiling as a Novel Predictive Tool for Operational Tolerance in Pediatric Liver Transplantation: A Single-center Study
This study aimed to identify serum microRNAs (miRNA) as a predictive tool for operational tolerance in pediatric liver transplantation (LT).
Potential Biomarkers of Therapeutic Response to ECP in Solid Organ Transplantation
One of the major hurdles in solid organ transplantation is graft rejection, which must be prevented with lifelong general immunosuppression. However, modern maintenance immunosuppression is accompanied by serious side effects, such as an increased risk of infection and malignancies. The search for alternative therapies specifically controlling allogeneic responses is fueling renewed interest in extracorporeal photopheresis (ECP).

DICG & TTS @ WCN 2026 - Yokohama, Japan

Join TTS at WCN 2026 — Discover the sessions we’ll be contributing to and be part of the conversation.
We hope to see you there!


ISN-DICG Joint Session: Organ Trafficking and Transplant Tourism — New Approaches for Prevention

March 30 - 15:50 - 16:50

Mandatory Reporting of Suspicious Cases

Maria Amalia Matamoros

Incentives to Reduce Organ Shortage

Khalida Bulhan - Soki

Addressing Inequities to Prevent Organ Trafficking and Transplant Tourism

Lilia Cervantes

ISN-TTS Joint Session

Maximising Opportunities and Resources in Kidney Transplant Care
March 31 - 09:10 - 10:40

Understanding Gender Disparities in Kidney Transplantation - a Causal Inference Approach

Jessica Harding

Pragmatic Medicine - Learning From the Indian Experience

Shyam Bihari Bansal

Strategies to Help Kidney Transplant Recipients Navigate Through the Complex Medical System Using Patient Navigation

Germaine Wong

Reducing the Environmental Footprint in Transplantation

Ivo Laranjinha

In the News


Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada

Используйте Вавада казино для игры с бонусом — активируйте промокод и начните выигрывать уже сегодня!